APRIL suppression sustained through 12 weeks, supporting Q12W dosing interval~70% reduction in Gd-IgA1 at 12 weeks ~33-day ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for ...
The Amgen Foundation today announced a new $13.4 million commitment to the Amgen Biotech Experience (ABE), a global educ ...
Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, has hosted the 2026 International Synthetic ...
Tempus AI delivers robust 22% YoY revenue growth, forecasting $1.6bn in 2026 and demonstrating strong commercial traction.
COL-5671, a highly selective oral SIK3 inhibitor, demonstrated a favorable safety and pharmacokinetic (PK) profilePharmacodynamic (PD) data ...
Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...
VITEEE 2027 online registration begins at viteee.vit.ac.in. Check application deadlines, eligibility criteria, exam pattern, ...
TUMI's Holiday Edit Celebrates the Art of Giving Through Craftsmanship and Considered Design NEW YORK, Oct. 19, 2026 ...
What if a weapon against some of the world’s most stubborn bacteria were hiding in the soil beneath our feet? Could these ...
The lead antibody is in Phase 2 studies for asthma, COPD and atopic dermatitis; a fourth study is planned, with data from all ...
Chris Zeng, Overseas Business Manager at Superteam Wheels, commented: "The MATIC S68 is the result of extensive development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results